Form 8-K - Current report:
SEC Accession No. 0001641172-25-005506
Filing Date
2025-04-21
Accepted
2025-04-21 12:38:15
Documents
14
Period of Report
2025-04-16
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43373
2 ex16-1.htm EX-16.1 4563
  Complete submission text file 0001641172-25-005506.txt   225961

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE juns-20250416.xsd EX-101.SCH 3051
4 XBRL LABEL FILE juns-20250416_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE juns-20250416_pre.xml EX-101.PRE 22383
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3783
Mailing Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477
Business Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 (561) 406-6154
JUPITER NEUROSCIENCES, INC. (Filer) CIK: 0001679628 (see all company filings)

EIN.: 474828381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41265 | Film No.: 25851827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)